Annual EBIT:
-$150.92M-$50.09M(-49.68%)Summary
- As of today, VKTX annual earnings before interest & taxes is -$150.92 million, with the most recent change of -$50.09 million (-49.68%) on December 31, 2024.
- During the last 3 years, VKTX annual EBIT has fallen by -$95.24 million (-171.04%).
- VKTX annual EBIT is now -149178.93% below its all-time high of -$101.10 thousand, reached on December 31, 2013.
Performance
VKTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$74.57M-$19.11M(-34.44%)Summary
- As of today, VKTX quarterly earnings before interest & taxes is -$74.57 million, with the most recent change of -$19.11 million (-34.44%) on June 30, 2025.
- Over the past year, VKTX quarterly EBIT has dropped by -$40.52 million (-118.99%).
- VKTX quarterly EBIT is now -2330337.50% below its all-time high of -$3200.00, reached on March 31, 2013.
Performance
VKTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$212.84M-$40.52M(-23.51%)Summary
- As of today, VKTX TTM earnings before interest & taxes is -$212.84 million, with the most recent change of -$40.52 million (-23.51%) on June 30, 2025.
- Over the past year, VKTX TTM EBIT has dropped by -$88.16 million (-70.71%).
- VKTX TTM EBIT is now -194094.34% below its all-time high of -$109.60 thousand, reached on December 31, 2012.
Performance
VKTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
VKTX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -49.7% | -119.0% | -70.7% |
| 3Y3 Years | -171.0% | -323.0% | -256.0% |
| 5Y5 Years | -361.7% | -680.7% | -442.7% |
VKTX EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -171.0% | at low | -360.4% | at low | -240.1% | at low |
| 5Y | 5-Year | -361.7% | at low | -657.6% | at low | -442.7% | at low |
| All-Time | All-Time | >-9999.0% | at low | >-9999.0% | at low | >-9999.0% | at low |
VKTX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$74.57M(-34.4%) | -$212.84M(-23.5%) |
| Mar 2025 | - | -$55.47M(-20.0%) | -$172.32M(-14.2%) |
| Dec 2024 | -$150.92M(-49.7%) | -$46.24M(-26.5%) | -$150.92M(-12.7%) |
| Sep 2024 | - | -$36.56M(-7.3%) | -$133.97M(-7.5%) |
| Jun 2024 | - | -$34.05M(+0.1%) | -$124.68M(-9.0%) |
| Mar 2024 | - | -$34.07M(-16.3%) | -$114.36M(-13.4%) |
| Dec 2023 | -$100.83M(-43.3%) | -$29.29M(-7.4%) | -$100.83M(-9.8%) |
| Sep 2023 | - | -$27.27M(-14.8%) | -$91.83M(-13.7%) |
| Jun 2023 | - | -$23.74M(-15.6%) | -$80.76M(-8.2%) |
| Mar 2023 | - | -$20.54M(-1.3%) | -$74.65M(-6.1%) |
| Dec 2022 | -$70.36M(-26.4%) | -$20.28M(-25.2%) | -$70.36M(-12.4%) |
| Sep 2022 | - | -$16.20M(+8.1%) | -$62.58M(-4.7%) |
| Jun 2022 | - | -$17.63M(-8.5%) | -$59.79M(-3.6%) |
| Mar 2022 | - | -$16.25M(-29.9%) | -$57.70M(-3.6%) |
| Dec 2021 | -$55.68M(-30.5%) | -$12.51M(+6.7%) | -$55.68M(-2.3%) |
| Sep 2021 | - | -$13.40M(+13.8%) | -$54.44M(-7.0%) |
| Jun 2021 | - | -$15.54M(-9.2%) | -$50.88M(-13.3%) |
| Mar 2021 | - | -$14.23M(-26.3%) | -$44.89M(-7.9%) |
| Dec 2020 | -$42.66M(-30.5%) | -$11.27M(-14.5%) | -$41.61M(-6.1%) |
| Sep 2020 | - | -$9.84M(-3.0%) | -$39.22M(-6.5%) |
| Jun 2020 | - | -$9.55M(+12.8%) | -$36.81M(+0.0%) |
| Mar 2020 | - | -$10.95M(-23.4%) | -$36.83M(-12.7%) |
| Dec 2019 | -$32.69M | -$8.87M(-19.3%) | -$32.69M(-12.5%) |
| Sep 2019 | - | -$7.44M(+22.3%) | -$29.05M(-3.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$9.57M(-40.6%) | -$28.21M(-12.1%) |
| Mar 2019 | - | -$6.81M(-29.9%) | -$25.17M(-16.2%) |
| Dec 2018 | -$26.16M(-37.2%) | -$5.24M(+20.6%) | -$21.66M(-7.0%) |
| Sep 2018 | - | -$6.60M(-1.1%) | -$20.25M(-3.9%) |
| Jun 2018 | - | -$6.53M(-98.2%) | -$19.49M(-9.5%) |
| Mar 2018 | - | -$3.29M(+14.0%) | -$17.80M(+7.8%) |
| Dec 2017 | -$19.07M(-37.7%) | -$3.83M(+34.5%) | -$19.29M(-3.3%) |
| Sep 2017 | - | -$5.84M(-20.9%) | -$18.68M(-15.2%) |
| Jun 2017 | - | -$4.83M(-0.9%) | -$16.21M(-11.5%) |
| Mar 2017 | - | -$4.79M(-49.2%) | -$14.54M(-12.5%) |
| Dec 2016 | -$13.85M(-15.4%) | -$3.21M(+4.9%) | -$12.92M(+11.2%) |
| Sep 2016 | - | -$3.37M(-6.6%) | -$14.55M(+7.1%) |
| Jun 2016 | - | -$3.17M(+0.2%) | -$15.66M(+22.0%) |
| Mar 2016 | - | -$3.17M(+34.4%) | -$20.09M(+10.4%) |
| Dec 2015 | -$12.00M(+48.9%) | -$4.84M(-7.8%) | -$22.42M(-27.5%) |
| Sep 2015 | - | -$4.49M(+40.9%) | -$17.58M(-34.2%) |
| Jun 2015 | - | -$7.59M(-38.0%) | -$13.10M(+53.6%) |
| Mar 2015 | - | -$5.50M(+75.8%) | -$28.22M(-23.0%) |
| Dec 2014 | -$23.47M(>-9900.0%) | - | - |
| Jun 2014 | - | -$22.71M(>-9900.0%) | -$22.93M(-9576.2%) |
| Mar 2014 | - | -$220.00K(-1194.1%) | -$237.00K(-82.6%) |
| Dec 2013 | -$101.10K(+7.8%) | - | - |
| Jun 2013 | - | -$17.00K(-431.3%) | -$129.80K(-15.1%) |
| Mar 2013 | - | -$3200.00(+97.1%) | -$112.80K(-2.9%) |
| Dec 2012 | -$109.60K | -$109.60K | -$109.60K |
FAQ
- What is Viking Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Viking Therapeutics, Inc.?
- What is Viking Therapeutics, Inc. annual EBIT year-on-year change?
- What is Viking Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Viking Therapeutics, Inc.?
- What is Viking Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Viking Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Viking Therapeutics, Inc.?
- What is Viking Therapeutics, Inc. TTM EBIT year-on-year change?
What is Viking Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of VKTX is -$150.92M
What is the all-time high annual EBIT for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high annual earnings before interest & taxes is -$101.10K
What is Viking Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, VKTX annual earnings before interest & taxes has changed by -$50.09M (-49.68%)
What is Viking Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of VKTX is -$74.57M
What is the all-time high quarterly EBIT for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is -$3200.00
What is Viking Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, VKTX quarterly earnings before interest & taxes has changed by -$40.52M (-118.99%)
What is Viking Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of VKTX is -$212.84M
What is the all-time high TTM EBIT for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high TTM earnings before interest & taxes is -$109.60K
What is Viking Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, VKTX TTM earnings before interest & taxes has changed by -$88.16M (-70.71%)